These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36289109)

  • 1. Set and setting in microdosing: an oft-overlooked principle.
    Hartogsohn I; Petranker R
    Psychopharmacology (Berl); 2022 Dec; 239(12):3771-3777. PubMed ID: 36289109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.
    Petranker R; Anderson T; Maier LJ; Barratt MJ; Ferris JA; Winstock AR
    J Psychopharmacol; 2022 Jan; 36(1):85-96. PubMed ID: 33591231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
    Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
    J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.
    Liokaftos D
    Int J Drug Policy; 2021 Sep; 95():103099. PubMed ID: 33518382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
    Kaypak AC; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosing with classical psychedelics: Research trajectories and practical considerations.
    Wong A; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):675-690. PubMed ID: 36317302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic microdosing benefits and challenges: an empirical codebook.
    Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E
    Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
    Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS
    Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
    Kuypers KP; Ng L; Erritzoe D; Knudsen GM; Nichols CD; Nichols DE; Pani L; Soula A; Nutt D
    J Psychopharmacol; 2019 Sep; 33(9):1039-1057. PubMed ID: 31303095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing Psychedelics and MDMA.
    Liechti ME; Holze F
    Curr Top Behav Neurosci; 2022; 56():3-21. PubMed ID: 34734392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motives and Side-Effects of Microdosing With Psychedelics Among Users.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):426-434. PubMed ID: 31152167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.
    van Elk M; Fejer G; Lempe P; Prochazckova L; Kuchar M; Hajkova K; Marschall J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1705-1720. PubMed ID: 33928421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.
    Ona G; Bouso JC
    Neurosci Biobehav Rev; 2020 Dec; 119():194-203. PubMed ID: 33031815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of microdosing psychedelics in depression.
    Kuypers KPC
    Ther Adv Psychopharmacol; 2020; 10():2045125320950567. PubMed ID: 32922736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic Microdosing: A Subreddit Analysis.
    Lea T; Amada N; Jungaberle H
    J Psychoactive Drugs; 2020; 52(2):101-112. PubMed ID: 31648596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.
    Andersson M; Kjellgren A
    Harm Reduct J; 2019 Nov; 16(1):63. PubMed ID: 31779667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
    Sousa TR; Rema J; Machado S; Novais F
    Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.